Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | APLNR | P35414 | 2/20 | 0.63 |
| ▸ | TFPI | P10646 | 6/20 | 0.61 |
| ▸ | NPY2R | P49146 | 8/20 | 0.60 |
| ▸ | NPY4R | P50391 | 8/20 | 0.60 |
| ▸ | NPY5R | Q15761 | 8/20 | 0.60 |
| ▸ | NPY1R | P25929 | 6/20 | 0.60 |
| ▸ | C5AR1 | P21730 | 1/20 | 0.59 |
| ▸ | MC4R | P32245 | 1/20 | 0.59 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29526390 | 0.98 | APLNR (0.64) | APLNRTFPINPY2RNPY4RNPY5R | |
| SCHEMBL29525492 | 0.97 | APLNR (0.64) | APLNRTFPIMC4R | |
| SCHEMBL29526046 | 0.97 | APLNR (0.64) | APLNRTFPINPY2RNPY4RNPY5R | |
| SCHEMBL29525577 | 0.97 | APLNR (0.64) | APLNRTFPINPY2RNPY4RNPY5R | |
| SCHEMBL29403150 | 0.94 | GHSR (0.66) | APLNRTFPINPY2RNPY4RNPY5R | |
| SCHEMBL30166497 | 0.93 | APLNR (0.62) | APLNRTFPINPY2RNPY4RNPY5R | |
| SCHEMBL18787566 | 0.92 | APLNR (0.61) | APLNRTFPINPY2RNPY4RNPY5R | |
| SCHEMBL29542556 | 0.92 | TFPI (0.70) | TFPINPY2RNPY4RNPY5RNPY1R | |
| SCHEMBL5498547 | 0.92 | APLNR (0.60) | APLNRTFPINPY2RNPY4RNPY5R | |
| SCHEMBL29587191 | 0.89 | F2 (0.64) | APLNRC5AR1MC4R |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20220401520-A1 | METHODS OF TREATING MILD BRAIN INJURY | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA | 2022-12-22 | — | — | US | claimed |
| US-11241483-B2 | Methods of treating mild brain injury | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2022-02-08 | — | — | US | claimed |
| US-20230330187-A1 | USE OF GHRELIN OR GHRELIN VARIANT FOR INCREASING DOSE INTENSITY OF CHEMOTHERAPEUTIC AGENTS IN PATIENTS WITH CANCER | OXEIA BIOPHARMACEUTICALS INC (US) | 2023-10-19 | — | — | US | disclosed |
| US-20220401520-A1 | METHODS OF TREATING MILD BRAIN INJURY | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA | 2022-12-22 | — | — | US | disclosed |
| US-11241483-B2 | Methods of treating mild brain injury | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2022-02-08 | — | — | US | disclosed |